Ozempic Is About to Go Generic in India, China and Canada

By: Rebecca Robbins, Meaghan Tobin, Eshe Nelson, Alex Travelli and Pragati K.B.

On: March 19, 2026, 12:00 am EDT

URL has been copied successfully!

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

Share this story:

This post was originally published here

Previous Post:How the Trump White House tries to sell war and death as a game

Next Post:Nomura's Willcox: BoJ More Likely To Hike in April